Amicus Therapeutics, Inc. Share Price
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 24/04/2026 BST
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-29 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 4.04B 3.75B 3.41B 6.44B 432B 6.54B 45.06B 17.67B 225B 17.08B 16.71B 718B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.18B 3.87B 3.52B 6.65B 446B 6.75B 46.53B 18.24B 233B 17.63B 17.26B 742B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 6 months | +0.28% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 8.09 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 26/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/04/26 | Issuer sale | General Counsel | 1,264,993 | 0.4029% | ||
| 27/04/26 | Issuer sale | Director | 395,940 | 0.1261% | ||
| 27/04/26 | Issuer sale | Chairman | 419,487 | 0.1336% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +78.67% | +37.22% | 4.55B | |
| -6.60% | -8.56% | +42.79% | +64.16% | 65B | |
| -4.09% | -0.11% | +2.31% | +54.81% | 51.19B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 51.2B | |
| -1.53% | +2.70% | +29.72% | +34.13% | 43.93B | |
| -1.34% | +4.12% | +16.05% | +112.18% | 41.96B | |
| -5.97% | -6.22% | +258.21% | +421.57% | 38.14B | |
| +6.53% | +8.02% | +15.74% | +53.94% | 33.24B | |
| -0.90% | -10.49% | +31.48% | -1.63% | 25.2B | |
| -2.76% | -9.54% | -16.53% | -9.55% | 22.03B | |
| Average | -1.64% | -1.48% | +46.86% | +80.86% | 37.65B | |
| Weighted average by Cap. | -2.27% | -1.19% | +43.99% | +87.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 470M 435M 396M 747M 50.14B 759M 5.23B 2.05B 26.16B 1.98B 1.94B 83.41B | 634M 564M 523M 475M 897M 60.19B 911M 6.28B 2.46B 31.41B 2.38B 2.33B 100B |
| Net income | -56.11M -49.87M -46.23M -42.06M -79.36M -5.32B -80.64M -556M -218M -2.78B -211M -206M -8.86B | -27.11M -24.1M -22.34M -20.32M -38.35M -2.57B -38.96M -268M -105M -1.34B -102M -99.58M -4.28B |
| Net Debt | 194M 172M 160M 145M 274M 18.38B 278M 1.92B 752M 9.59B 727M 711M 30.58B | 149M 132M 123M 112M 211M 14.12B 214M 1.47B 578M 7.37B 559M 547M 23.5B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
